Researcher.Life Logo

Molecular and Cellular Oncology : Impact Factor & More

eISSN: 2372-3556pISSN: 2372-3556
JournalOpen Access

Key Metrics

CiteScore
2.6
SJR
Q4Cancer Research
SNIP
0.26
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Molecular and Cellular Oncology

Molecular and Cellular Oncology Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher TAYLOR & FRANCIS INC
Language English
Frequency Bi-monthly
Article Processing ChargesGBP 1250 | USD 1590 | EUR 1450
Publication Time6
Editorial Review ProcessAnonymous peer review
General Details
LanguageEnglish
FrequencyBi-monthly
Publication Start Year2014
Publisher URLVisit website
Website URLVisit website
Publication Details
PlagiarismVisit website
Publication Time 6
Waiver PolicyVisit website
Editorial Review Detail
Editorial TeamVisit website
Review ProcessAnonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
Deposit PolicySherpa/Romeo
License typeCC BY, CC BY-NC
OA statementVisit website
View less

Planning to publish in Molecular and Cellular Oncology ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Molecular and Cellular Oncology

Exploration of the diagnostic and therapeutic potential of the nucleocytoplasmic shuttling protein TMUB1 by inducing G0/G1 cell cycle arrest in ovarian cancer
  • 31 Dec 2026
  • Molecular & Cellular Oncology
MRNA vaccines in oncology: personalized cancer immunization and neoantigen targeting
  • 31 Dec 2026
  • Molecular & Cellular Oncology
The LNK adaptor protein: a dual regulator of proliferation and migration in solid tumors
  • 31 Dec 2026
  • Molecular & Cellular Oncology
Lactylation-related genes signature panel in hepatocellular carcinoma reveals the prognostic and therapeutic optimization
  • 22 Feb 2026
  • Molecular & Cellular Oncology
Loss of Schwann cell’s normal rhythmic core clock gene expression and gain of rhythmic expression of oncogenic driver genes in malignant NF1-associated peripheral nerve sheath tumor
  • 31 Dec 2025
  • Molecular & Cellular Oncology
Exploration of the diagnostic and therapeutic potential of the nucleocytoplasmic shuttling protein TMUB1 by inducing G0/G1 cell cycle arrest in ovarian cancer
  • 31 Dec 2026
  • Molecular & Cellular Oncology
MRNA vaccines in oncology: personalized cancer immunization and neoantigen targeting
  • 31 Dec 2026
  • Molecular & Cellular Oncology
The LNK adaptor protein: a dual regulator of proliferation and migration in solid tumors
  • 31 Dec 2026
  • Molecular & Cellular Oncology
Lactylation-related genes signature panel in hepatocellular carcinoma reveals the prognostic and therapeutic optimization
  • 22 Feb 2026
  • Molecular & Cellular Oncology
Loss of Schwann cell’s normal rhythmic core clock gene expression and gain of rhythmic expression of oncogenic driver genes in malignant NF1-associated peripheral nerve sheath tumor
  • 31 Dec 2025
  • Molecular & Cellular Oncology

FAQs on Molecular and Cellular Oncology